Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD) - Horita, N; Goto, A; Shibata, Y (Cochrane Database Syst Rev, 2017)
, et al.